Status:
COMPLETED
Pharmacopuncture Therapy for Chronic Knee Pain
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Chronic Knee Pain
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
This study is a pragmatic randomized controlled trial. Condition/disease: Chronic Knee Pain. Intervention: Pharmacopuncture
Detailed Description
Knee pain can have various causes. It may result from tears and injuries to structures or from inflammation due to various diseases. Chronic pain is often caused by overuse injuries, inflammation, or ...
Eligibility Criteria
Inclusion
- Patients whose NRS (Numeric Rating Scale) of knee pain is 5 or higher
- Patients whose symptoms persist for more than 3 months
- Patients who are between 19 and 70 years of age
- Patients who, after receiving a detailed explanation of the clinical study and fully understanding it, voluntarily decide to participate and agree in writing to comply with the precautions.
Exclusion
- Patients who have been diagnosed with a specific serious disease that may cause knee pain (acute fracture, dislocation, traumatic damage to ligaments and cartilage, etc.)
- If the cause of the pain is caused by a disease other than the knee (tumor, fibromyalgia, rheumatoid arthritis, gout, lumbar disc herniation, etc.)
- Cases that occur due to a traumatic event and require surgical intervention due to suspected acute fracture, dislocation, ligament and cartilage damage
- Patients who diagnosed other chronic diseases (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results.
- Patients who are currently taking steroids, immunosuppressants, drugs for mental illness, or other drugs that may affect the results of the study
- Patients who acupuncture treatment is inappropriate or unsafe: Patients with bleeding disorders, those receiving anticoagulant treatment, and patients with severe diabetes at risk of infection.
- Patients who have taken drugs that may affect pain, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or have received herbal acupuncture or physical therapy within the past week
- Patients who are pregnant, planning to become pregnant, or are breastfeeding
- Patients within 3 months after knee surgery or if knee replacement surgery was performed
- Patients who has been less than 1 month since you finished participating in another clinical study, or if you are planning to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection
- Patients who difficult to fill out the consent form for research participation
- Other cases where participation in clinical research is difficult in the judgment of the researcher.
Key Trial Info
Start Date :
December 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06505681
Start Date
December 28 2022
End Date
November 30 2023
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, South Korea, 35262